
Meusinvest (Noshaq)
Description
Noshaq, formerly known as Meusinvest, stands as a pivotal financial partner dedicated to fostering economic growth within the Liège region of Belgium. With a rich history spanning over 35 years, the organization has consistently provided diverse financing solutions to businesses, ranging from nascent startups to established enterprises undergoing expansion or ownership transitions. Their strategic objective is to support the local economy by offering tailored investment vehicles, including equity, subordinated loans, and convertible loans, across various stages of a company's lifecycle.
The firm's investment scope is broad, encompassing seed and start-up funding, growth and development capital, management buy-outs (MBOs) and buy-ins (MBIs), and even real estate projects. For early-stage and innovation-focused ventures, Noshaq typically deploys initial investments ranging from €50,000 to €500,000. However, for more mature companies seeking growth capital or undergoing transmission, their interventions can extend from €250,000 up to several million euros, often participating in co-investment rounds to facilitate larger capital injections.
Noshaq boasts an impressive track record, having invested in more than 480 companies throughout its operational history. This extensive portfolio underscores its commitment to the regional business ecosystem. Collectively, the companies within Noshaq's portfolio contribute significantly to the local economy, generating a substantial €4.6 billion in turnover and supporting approximately 15,000 jobs. The organization's long-standing presence and flexible investment approach make it a key player in the Belgian venture and growth capital landscape, particularly for businesses rooted in the Liège area.
Investor Profile
Meusinvest (Noshaq) has backed more than 71 startups, with 6 new investments in the last 12 months alone. The firm has led 6 rounds, about 8% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in Belgium, France, Germany.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $54K – $5.4M.
Stage Focus
- Series A (30%)
- Seed (27%)
- Series Unknown (18%)
- Series B (14%)
- Series D (3%)
- Convertible Note (1%)
- Undisclosed (1%)
- Series C (1%)
- Series E (1%)
- Pre Seed (1%)
Country Focus
- Belgium (66%)
- France (21%)
- Germany (4%)
- United Kingdom (3%)
- United States (1%)
- Luxembourg (1%)
- Switzerland (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Health Diagnostics
- Manufacturing
- Pharmaceutical
- Therapeutics
- Life Science
- Sports
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.